Humana Inc.

Equities

HUM

US4448591028

Managed Healthcare

Real-time Estimate Cboe BZX 11:00:45 2024-04-24 am EDT 5-day change 1st Jan Change
311.1 USD -5.13% Intraday chart for Humana Inc. -2.64% -31.21%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Sector Update: Health Care Stocks Rise Pre-Bell Wednesday MT
TD Cowen Lowers Humana Price Target to $396 from $427 MT
Nasdaq, S&P futures advance on tech boost, earnings glee RE
Humana's Q1 Adjusted Earnings Fall, Revenue Rises; 2024 Adjusted EPS Outlook Reaffirmed MT
Tranche Update on Humana Inc.'s Equity Buyback Plan announced on February 15, 2024. CI
Humana Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Humana beats first-quarter profit estimates on strength of Medicare business RE
Earnings Flash (HUM) HUMANA Posts Q1 EPS $7.23, vs. Street Est of $6.00 MT
Humana Inc. Revises Earnings Guidance for the Year Ending December 31, 2024 CI
Cigna, Humana Merger Now Seems Plausible, Jefferies Says MT
Mizuho Adjusts Price Target on Humana to $385 From $400 MT
Jefferies Lowers Humana Price Target to $381 from $411 MT
Declaration of Voting Results by Humana Inc CI
Humana Keeps Quarterly Dividend at $0.885 a Share, Payable July 26 to Shareholders of Record June 28 MT
Humana Inc. Declares Cash Dividend, Payable on July 26, 2024 CI
Zacks Upgrades Humana to Neutral From Underperform MT
CVS, Cigna, Humana, UnitedHealth - Congress wants to clean up PBMs Our Logo
Explainer-Why are US pharmacy benefit managers under fire? RE
Wall St set for higher open as upbeat earnings obscure Mideast jitters RE
Sector Update: Health Care Stocks Softer Late Afternoon MT
Sector Update: Health Care Stocks Gain Monday Afternoon MT
Sector Update: Health Care MT
Health Care Stocks Rise After Florida's Medicaid Contract Award Announcement MT
Truist Securities Adjusts Price Target on Humana to $355 From $400 MT
Wells Fargo Cuts Price Target on Humana to $350 From $413, Maintains Overweight Rating MT
Chart Humana Inc.
More charts
Humana Inc. is one of the leading health insurance and complementary medical services companies in the United States. Revenues break down by activity as follows: - health insurance services (95.2%): to recipients of government-sponsored plans, to groups of employers and individuals; - services (3.8%): health care, primary care, home clinical care, health coaching services, prescription of drugs, pharmaceutical services, etc.; - other (1%).
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
23
Last Close Price
328 USD
Average target price
388.6 USD
Spread / Average Target
+18.50%
Consensus
  1. Stock Market
  2. Equities
  3. HUM Stock
  4. News Humana Inc.
  5. Wells Fargo Adjusts Humana's Price Target to $514 from $512, Keeps Overweight Rating